JAK2, Janus kinase 2, 3717

N. diseases: 644; N. variants: 54
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders. 21942426 2011
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders. 20434300 2010
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human Essential thrombocythemia: past and present. 19636672 2009
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden. 19154659 2009
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human [Primary thrombocythemia: diagnosis and therapy]. 16896569 2006
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. 16484586 2006
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human A gain-of-function mutation of JAK2 in myeloproliferative disorders. 15858187 2005
CUI: C3489628
Disease: Thrombocytosis, Autosomal Dominant
Thrombocytosis, Autosomal Dominant
0.300 Biomarker disease CTD_human Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. 15781101 2005